4-Quinazolinamine - CAS 15018-66-3

Catalog:	BB010498
Product Name:	4-Quinazolinamine
CAS:	15018-66-3
Synonyms:	quinazolin-4-amine

Technical Data

Safety and Hazards

Patents

Literatures

Computed Properties

IUPAC Name:	quinazolin-4-amine
Description:	4-Quinazolinamine (CAS# 15018-66-3) is a useful research chemical.
Molecular Weight:	145.16
Molecular Formula:	C8H7N3
Canonical SMILES:	C1=CC=C2C(=C1)C(=NC=N2)N
InChI:	InChI=1S/C8H7N3/c9-8-6-3-1-2-4-7(6)10-5-11-8/h1-5H,(H2,9,10,11)
InChI Key:	DRYRBWIFRVMRPV-UHFFFAOYSA-N
Boiling Point:	328.3 °C at 760 mmHg
Density:	1.292 g/cm³
MDL:	MFCD00092016
LogP:	1.79320

Publication Number	Title	Priority Date
CN-113200964-A	18F-labeled EGFR positron imaging agent and preparation method and application thereof	20210425
CN-112661803-A	Synthetic method of On-DNA 4-amino quinazoline compound in construction of DNA coding compound library	20201217
CN-112457260-A	N-heterocyclic aryl quinazoline-4-amine compound and preparation method thereof	20201208
CN-112300125-A	Naphthalimide-polyamine conjugate and preparation method and application thereof	20201102
CN-112079821-A	Conjugate formed by orlistat and phenylaminopyrimidine compound and preparation method and application thereof	20200914

PMID	Publication Date	Title	Journal
22704892	20120715	Synthesis and evaluation of novel F-18 labeled 4-aminoquinazoline derivatives: potential PET imaging agents for tumor detection	Bioorganic & medicinal chemistry letters
22590418	20120501	(E)-2-[2-(4-Chloro-benzyl-idene)hydrazin-1-yl]-4-{[3-(dimethyl-aza-nium-yl)prop-yl]amino}-quinazolin-1-ium bis-(perchlorate)	Acta crystallographica. Section E, Structure reports online
22169262	20120101	Design, synthesis and antitumor activity of 4-aminoquinazoline derivatives targeting VEGFR-2 tyrosine kinase	Bioorganic & medicinal chemistry letters
21961726	20111002	Role of protein kinase C and epidermal growth factor receptor signalling in growth stimulation by neurotensin in colon carcinoma cells	BMC cancer
21306896	20110301	Investigation of a novel molecular descriptor for the lead optimization of 4-aminoquinazolines as vascular endothelial growth factor receptor-2 inhibitors: application for quantitative structure-activity relationship analysis in lead optimization	Bioorganic & medicinal chemistry letters

Related Products

Online Inquiry

Name:

* Phone:

* Service & Products of Interested:

Project Description:

* Quantity:

* Email:

* Verification Code:

Customer Support

If the product you need is not in our catalog, please contact us in time to submit your needs. You can help our website get better and better. Why not submit the request today?

Submit Requirement

Customer Centered

Global Delivery

Warehouses in multiple cities to ensure fast delivery

Quality Assurance

Strict process parameter control to ensure product quality

Large Stock

> 20,000 building blocks and intermediates from stock

Process Scale-up

Process scale-up from lab to industrial scale

Flexible Batch Size

Flexible batch size for diverse industrial demands

Related Functional Groups

Quinazolines

[20028-72-2]
2-Amino-6-fluoroquinazoline
[29113-33-5]
Ethyl 4-quinazolone-2-carboxylate
[267243-68-5]
Intermediate 2 of Canertinib
[67092-21-1]
2,5,6-Trichloroquinazoline
[19815-16-8]
4-Chloro-6-nitroquinazoline
[103884-20-4]
2,5-Diamino-6-nitroquinazolin-4(3H)-one

Customers Also Viewed

[730-46-1]
5-Dodecyldihydro-2(3H)-Furanone
[1007504-11-1]
1H-Pyrazole-4-methanol, -α-,1,3,5-tetramethyl-
[1866059-82-6]
1,1,2,2-Tetrafluoro-3-methylsulfonylpropane
[2973-17-3]
N-Allylmaleimide
[119-24-4]
Folic Acid EP Impurity D (Methotrexate EP Impurity D)
[10340-23-5]
cis-3-Nonen-1-ol

INDUSTRY LEADERS TRUST OUR PRODUCTS

Phone

US & Canada (Toll free):

UK:

International:

E-mail & Fax

E-mail:

Fax:

Address

USA:

UK:

Our Products

Inquiry Basket

Loading ......

Delete selected Go to checkout

GHS Hazard Statement:	H302 (75%): Harmful if swallowed [Warning Acute toxicity, oral]
Precautionary Statement:	P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501
Signal Word:	Warning

Complexity:	137
Compound Is Canonicalized:	Yes
Covalently-Bonded Unit Count:	1
Defined Atom Stereocenter Count:	0
Defined Bond Stereocenter Count:	0
Exact Mass:	145.063997236
Formal Charge:	0
Heavy Atom Count:	11
Hydrogen Bond Acceptor Count:	3
Hydrogen Bond Donor Count:	1
Isotope Atom Count:	0
Monoisotopic Mass:	145.063997236
Rotatable Bond Count:	0
Topological Polar Surface Area:	51.8 Å²
Undefined Atom Stereocenter Count:	0
Undefined Bond Stereocenter Count:	0
XLogP3:	1.3